Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06805461 · ClinicalTrials.gov registry record

PanTheR Registry Trial

A clinical trial of Solid Tumors, sponsored by RenovoRx.

Recruiting
Registry status
1,000
Enrollment target
3
Study locations

NCT06805461 is a study of Solid Tumors that is actively recruiting participants, run by RenovoRx. The registered enrollment target is 1,000 participants, above the 277-participant average among 125 other Solid Tumors trials with a reported enrollment target (261% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06805461, a study of Solid Tumors, is actively recruiting participants, sponsored by RenovoRx.

RECRUITING
Registry status
1,000 participants
Enrollment target
3
Study locations

Study Summary

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Conditions Studied

Solid Tumors

Interventions

  • DEVICE RenovoCath®

Study Locations (3)

Florida

  • Baptist Health South Florida - Coral Gables

Pennsylvania

  • University of Pennsylvania Medical Center - Pittsburgh

Vermont

  • The University of Vermont Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-08-01
Est. Completion 2029-09-03

Sponsor

RenovoRx

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06805461

The ClinicalTrials.gov registry entry for NCT06805461 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 277-participant average among 125 other Solid Tumors trials with a reported enrollment target (261% higher). The listed sponsor is RenovoRx, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which RenovoCath® is the first listed.

NCT06805461 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Pennsylvania, Vermont.

Frequently Asked Questions

What is clinical trial NCT06805461 about?

NCT06805461 is a clinical study titled "PanTheR Registry Trial". This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to ...

What is the current status of trial NCT06805461?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-08-01. Estimated completion is 2029-09-03.

What conditions does trial NCT06805461 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT06805461?

The interventions under investigation include: RenovoCath® (DEVICE).

Who is sponsoring clinical trial NCT06805461?

This trial is sponsored by RenovoRx, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06805461 being conducted?

This trial has 3 study locations across Florida, Pennsylvania, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.